Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection

Journal of Pathology

Volumn 180, Issue 4, 1996, Pages 434-440

  Kaminska, Renata ^a,c   Harvima, Ilkka T ^a   Naukkarinen, Anita ^a   Nilsson, Gunnar ^b   Horsmanheimo, Maija ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Herpes zoster; Mast cell; Protease

Indexed keywords

CHYMASE; PROTEINASE; PROTEINASE INHIBITOR; TRYPTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME HISTOCHEMISTRY; FEMALE; HERPES ZOSTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; PRIORITY JOURNAL; SKIN INFECTION;

ADULT; AGED; CHYMASES; FEMALE; HERPES ZOSTER; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MAST CELLS; MIDDLE AGED; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; SKIN; SKIN DISEASES, VIRAL; TRYPTASES;

EID: 0030474146     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199612)180:4<434::AID-PATH682>3.0.CO;2-B     Document Type: Article

References (29)

1. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37: 1509-1515.
2. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease composition. Proc Natl Acad Sci USA 1986; 83: 4464-4468.
3. TC type of human mast cell. J Immunol 1990; 145: 2652-2661.
4. Harvima IT, Naukkarinen A, Harvima RJ, Aalto M-L, Neittuanmaki H. Horsmanheimo M. Qualitative enzyme-histochemical analysis of tryptase-and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 1990; 282: 428-433.
5. Schwartz LB. Mast cells and their role in urticaria. J Am Acad Dermatol 1991; 25: 190-204.
6. Harvima IT, Naukkarinen A, Harvima RJ, Fräki JE. Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin. Arch Dermatol Res 1988; 280: 363-370.
7. Nishioka K, Kobayashi Y, Katayama I Takijiri C. Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987; 123: 205-208.
8. Levi-Schaffer F, Klapholz L, Kupietzky A, Weinrauch L, Shalit M, Okon E. Increased numbers of mast cells in pemphigus vulgaris skin lesions. A histochemical study. Acta Derm Venereal (Stockholm) 1991; 71: 269-271.
9. Sugiura H, Hirota Y, Uehara M. Heterogeneous distribution of mast cells in lichenified lesions of atopic dermatitis. Acta Derm Venereal I (Stockholm) Supl 1989; 144: 115-118.
10. Irani AA, Sampson HA, Schwartz LB. Mast cells in atopic dermatitis. Allergy 1989; 44 (Suppl 9): 31-34,
11. Naukkarinen A, Harvima I, Paukkonen K, Aalto M-L, Horsmanheimo M. Immunohistochemical analysis of sensory nerves, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 1993; 285: 341-346.
12. Naukkarinen A, Harvima IT, Aalto M-L, Horsmanheimo M. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Int J Dermatol 1994; 33: 361-366.
13. Takamori K, Ikeda S, Naito K, Manabe M, Ogawa H. The biological role of proteinases and their inhibitors in the pathogenesis of epidermolysis bullosa-recessive dystrophic and simplex types. In: Ogawa H, Lazarus GS, Hopsu-Havu VK, eds. The Biological Role of Proteinases and Their Inhibitors in Skin. Tokyo: University of Tokyo, 1985; 205-216.
14. Naito K, Morioka S, Nakajima S, Ogawa H. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis. J Invest Dermatol 1989; 93: 173-177.
15. Harvima IT, Naukkarinen A, Harvima RJ, Horsmanheimo M, Enzyme-and immunohistochemical localization of mast cell tryptase in psoriatic skin. Arch Dermatol Res 1989; 281: 387-391.
16. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988; 12: 345-355.
17. Huang R, Åbrink M, Gobl AE, et al. Expression of a mast cell tryptase in the human monocytic cell lines U-937 and Mono Mac 6. Scand J Immunol 1993; 38: 359-367.
18. Schechter NM, Sprows JL, Shoenberger OL, Lazarus GS, Cooperman BS. Rubin H. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem 1989; 264: 21308-21315.
19. Muraki R, Baba T, Iwasaki T, Sata T, Kurata T. Immunohistochemical study of skin lesions in herpes zoster. Virchows Arch A [Pathol Anat] 1992; 420: 71-76.
20. van Overveld FJ, Jorens G, Rampart M, de Backer W, Vermeire PA. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991; 21: 711-714.
21. Kubota Y. The effect of human anaphylatoxins and neutrophils on histamine release from isolated human skin mast cells. J Dermatol 1992; 19: 19-26.
22. Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 1989; 88: 70-78.
23. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium, association with expression of VCAM-1. J Immunol 1992; 148: 1086-1092.
24. Castells MC, Irani A-M, Sehwartz LB. Evaluation of human peripheral blood luekocytes for mast cell tryptase. J. Immunol 1987; 138: 2184-2189.
25. Wintroub BU, Mihm MC, Goetzl EJ, Soter NA, Austen KF. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med 1978; 298: 417-421.
26. Morioka S, Lazarus GS, Jensen PJ. involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. J Invest Dermatol 1987; 89: 474-477.
27. Stack MS, Johnson DA. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 1994; 269: 9416-9419.
28. Lohi J, Harvima I, Keski-Oja J, Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem 1992; 50: 337-349.
29. Briggaman RS, Schechter NM, Fräki J, Lazarus GS. Degradation of the epidermal -dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 1984; 160: 1027-1042.